❌

Normal view

There are new articles available, click to refresh the page.
Before yesterdayNYT: Science

Study Suggests Waiting Longer Before Withdrawing Life Support

17 May 2024 at 05:03
A review of a limited number of cases of unresponsive patients with severe traumatic brain injuries raised questions about a custom of making a decision within 72 hours.

Β© Shannon Stapleton/Reuters

A new study found that 42 percent of those who had continued life support recovered enough in the next year to have some degree of independence. A few even returned to their former lives.

FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer

16 May 2024 at 16:59
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.

Β© Joe Buglewicz for The New York Times

Martha Warren, 65, of Westerly, R.I., found out last year that she had small cell lung cancer, and joined the tarlatamab clinical trial. She said she now feels as good as before her diagnosis.

Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports

17 April 2024 at 06:15
The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.

Β© Brendan Mcdermid/Reuters

In a study, people with sleep apnea who were randomly assigned to take the weight-loss drug Zepbound had an average of about 30 fewer apnea episodes per hour.
❌
❌